查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1876472

全球骨髓移植市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032）

Bone marrow transplantation market Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 190 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research近期發布了一份關於全球骨髓移植市場的綜合報告。本報告詳細分析了關鍵市場趨勢，包括市場促進因素、新興趨勢、機會和挑戰。報告深入剖析了市場格局，相信能夠幫助相關人員做出明智的決策。

主要調查結果：

  • 骨髓移植市場規模（2025年）：116億美元
  • 預計市場價值（2032年）：157億美元
  • 全球市場成長率（2025-2032年年複合成長率）：4.5%

骨髓移植市場研究範圍：

骨髓移植市場涵蓋以健康幹細胞取代受損或壞死骨髓的醫療程序，廣泛用於治療血液疾病和免疫力缺乏。白血病和淋巴瘤等癌症發生率的不斷上升，以及細胞療法和移植技術的進步，正顯著推動全球對骨髓移植的需求。公眾意識的提高、支持性的法規結構以及完善的捐贈者登記系統也進一步促進了市場成長。

市場成長促進因素：

全球骨髓移植市場正穩定成長，主要促進因素是白血病、淋巴瘤和多發性骨髓瘤等骨髓惡性腫瘤發生率的上升。幹細胞採集和移植技術的進步提高了患者的治療效果和安全性，促進了該技術的廣泛應用。醫療基礎設施投資的增加和專業移植中心的擴建，尤其是在新興經濟體，也推動了市場成長。此外，各國政府和非營利組織為促進捐贈者登記和提高公眾對幹細胞捐贈的認知所做的努力，也支撐了全球對骨髓移植的需求。

市場限制：

儘管前景樂觀，骨髓移植市場仍面臨諸多限制。治療費用高和移植手術複雜是主要障礙，尤其是在中低收入國家。尋找匹配供體，特別是異基因移植供體，仍然是一項持續存在的挑戰。此外，移植後併發症（例如移植物抗宿主疾病）和高感染疾病風險會影響患者存活率，並阻礙移植手術的進行。另外，幹細胞研究和捐贈行為的監管障礙和倫理問題也可能在某些地區阻礙市場擴張。

市場機會：

骨髓移植市場蘊藏著巨大的發展機會，主要得益於再生醫學和細胞療法的研發。單倍體相合移植和臍帶血移植的發展，使得那些沒有完全匹配捐贈者的患者也能獲得移植機會。學術機構與生技公司之間日益緊密的合作，推動了移植技術和移植後護理的創新。拓展至南亞、拉丁美洲和非洲部分地區等尚未開發的市場，為市場提供了巨大的成長潛力，這些地區對先進癌症治療的需求成長。此外，數位健康平台和人工智慧驅動的供體匹配系統預計將在未來幾年內提升移植的成功率和效率。

本報告解答的關鍵問題：

  • 推動全球骨髓移植市場成長的主要因素有哪些？
  • 哪種移植類型和疾病適應症佔據最大的市場佔有率？
  • 科技創新如何影響移植手術和患者照護？
  • 骨髓移植市場的主要參與者有哪些？他們的戰略重點是什麼？
  • 新興地區和專科護理領域有哪些成長機會？

目錄

第1章 執行摘要

第2章 市場概覽

  • 市場範圍和定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 主要趨勢
  • 新冠疫情影響分析
  • 預測因子 - 相關性和影響

第3章 加值見解

  • 服務採用分析
  • 移植成本分析
  • 價值鏈分析
  • 疾病流行病學
  • 監管狀態
  • PESTLE分析

第4章 全球骨髓移植市場展望

  • 主要亮點
    • 市場規模和年成長率
    • 絕對商機
  • 市場規模分析與預測
    • 市場規模實績分析（2019-2024年）
    • 市場規模分析及預測（2025-2032年）
  • 全球骨髓移植市場展望：移植類型
    • 依移植類型分類的市場規模績效分析（2019-2024年）
    • 依移植類型分類的市場規模分析與預測（2025-2032年）
      • 自體骨髓移植
      • 異基因骨髓移植
      • 同基因移植
    • 市場吸引力分析：移植類型
  • 全球骨髓移植市場展望：適應症
    • 依適應症分類的市場規模表現分析（2019-2024年）
    • 依適應症分類的市場規模分析與預測（2025-2032年）
      • 白血病
      • 淋巴瘤
      • 多發性骨髓瘤
      • 再生障礙性貧血
      • 鐮狀細胞貧血症
      • 其他
    • 市場吸引力分析：適應症
  • 全球骨髓移植市場展望：終端用戶
    • 依最終用戶分類的市場規模績效分析（2019-2024年）
    • 依最終用戶分類的市場規模分析及預測（2025-2032年）
      • 醫院
      • 多學科診所
      • 門診手術中心
      • 癌症研究所
    • 市場吸引力分析：最終用戶

第5章 全球骨髓移植市場展望：依地區

  • 依地區分類的市場規模表現分析（2019-2024年）
  • 依地區分類的市場規模分析及預測（2025-2032年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：區域

第6章 北美骨髓移植市場展望

第7章 歐洲骨髓移植市場展望

第8章 東亞骨髓移植市場展望

第9章 南亞和大洋洲骨髓移植市場展望：

第10章 拉丁美洲骨髓移植市場展望：

第11章 中東與非洲骨髓移植市場展望：

第12章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP4288

Persistence Market Research has recently released a comprehensive report on the global Bone Marrow Transplantation Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Bone Marrow Transplantation Market Size (2025E): US$ 11.6 Bn
  • Projected Market Value (2032F): US$ 15.7 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.5%

Bone Marrow Transplantation Market - Report Scope:

The bone marrow transplantation market encompasses medical procedures used to replace damaged or destroyed bone marrow with healthy stem cells, widely utilized in the treatment of hematologic diseases and immune deficiencies. The increasing prevalence of cancers such as leukemia and lymphoma, coupled with advancements in cell therapy and transplant techniques, has significantly fueled the demand for bone marrow transplants globally. Rising awareness, supportive regulatory frameworks, and improvements in donor registries further enhance market growth.

Market Growth Drivers:

The global bone marrow transplantation market is witnessing steady growth, primarily driven by the rising incidence of hematologic malignancies such as leukemia, lymphoma, and multiple myeloma. Technological advancements in stem cell harvesting and transplantation techniques have improved patient outcomes and safety, thereby encouraging wider adoption. Increased investments in healthcare infrastructure and the expansion of specialized transplant centers, particularly in emerging economies, are contributing to market growth. Furthermore, initiatives by governments and non-profit organizations to increase donor registration and public awareness about stem cell donation are supporting the global demand for bone marrow transplantation.

Market Restraints:

Despite the positive outlook, the bone marrow transplantation market faces several restraints. High treatment costs and the complexity of transplant procedures pose significant barriers, particularly in low- and middle-income countries. Limited availability of compatible donors, especially for allogeneic transplants, remains a persistent challenge. Moreover, post-transplant complications, such as graft-versus-host disease (GVHD), and the high risk of infections continue to impact patient survival and deter some from pursuing transplantation. In addition, regulatory hurdles and ethical concerns surrounding stem cell research and donor practices may hamper market expansion in certain regions.

Market Opportunities:

The market for bone marrow transplantation holds promising opportunities driven by the increasing research in regenerative medicine and cellular therapies. The development of haploidentical and cord blood transplants has broadened the scope for patients lacking fully matched donors. Growing collaborations between academic institutions and biotechnology companies are fostering innovation in transplant techniques and post-transplant care. Expansion into untapped regions such as South Asia, Latin America, and parts of Africa, where the demand for advanced cancer treatment is rising, offers substantial growth prospects. Moreover, digital health platforms and AI-driven donor matching systems are expected to improve transplant success rates and efficiency in the coming years.

Key Questions Answered in the Report:

  • What are the primary factors driving the global bone marrow transplantation market's growth?
  • Which transplant types and disease indications account for the largest market share?
  • How are technological innovations influencing transplant procedures and patient care?
  • Who are the key players in the bone marrow transplantation market, and what are their strategic priorities?
  • What are the growth opportunities in emerging regions and specialized healthcare segments?

Competitive Intelligence and Business Strategy:

Leading companies in the global bone marrow transplantation market, such as Lonza Group Ltd., Merck Millipore Corporation, and Sanofi-Aventis LLC, are focusing on research and development of advanced stem cell products and transplant solutions. Firms like STEMCELL Technologies and ATCC Inc. are strengthening their offerings in cell processing and cryopreservation tools. Companies such as ReeLabs Pvt. Ltd. and HemaCare are emphasizing strategic collaborations with hospitals and cancer research institutes to improve access to donor registries and transplant services. Investment in infrastructure, development of cost-effective transplant kits, and geographic expansion remain central to competitive strategies in this market.

Companies Covered in This Report:

  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC
  • STEMCELL Technologies
  • American Type Culture Collection (ATCC) Inc.
  • ReeLabs Pvt. Ltd.
  • HemaCare

Market Segmentation:

By Type of Transplant

  • Autologous Bone Marrow Transplantation
  • Allogeneic Bone Marrow Transplantation
  • Syngeneic Transplantation

By Indication

  • Leukemia
  • Lymphoma
  • Myeloma
  • Aplastic Anemia
  • Sickle Cell Anemia
  • Others

By End-user

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institute

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bone Marrow Transplantation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Service Adoption Analysis
  • 3.2. Transplant Cost Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Disease Epidemiology
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis

4. Global Bone Marrow Transplantation Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Bone Marrow Transplantation Market Outlook: Type of Transplant
    • 4.3.1. Historical Market Size (US$ Bn) Analysis, By Type of Transplant, 2019-2024
    • 4.3.2. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
      • 4.3.2.1. Autologous Bone Marrow Transplantation
      • 4.3.2.2. Allogeneic Bone Marrow Transplantation
      • 4.3.2.3. Syngeneic Transplantation
    • 4.3.3. Market Attractiveness Analysis: Type of Transplant
  • 4.4. Global Bone Marrow Transplantation Market Outlook: Indication
    • 4.4.1. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2024
    • 4.4.2. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      • 4.4.2.1. Leukemia
      • 4.4.2.2. Lymphoma
      • 4.4.2.3. Myeloma
      • 4.4.2.4. Aplastic Anemia
      • 4.4.2.5. Sickle Cell Anemia
      • 4.4.2.6. Others
    • 4.4.3. Market Attractiveness Analysis: Indication
  • 4.5. Global Bone Marrow Transplantation Market Outlook: End User
    • 4.5.1. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
    • 4.5.2. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.2.1. Hospitals
      • 4.5.2.2. Multispecialty Clinics
      • 4.5.2.3. Ambulatory Surgical Centers
      • 4.5.2.4. Cancer Research Institutes
    • 4.5.3. Market Attractiveness Analysis: End User

5. Global Bone Marrow Transplantation Market Outlook: Region

  • 5.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.2.1. North America
    • 5.2.2. Europe
    • 5.2.3. East Asia
    • 5.2.4. South Asia and Oceania
    • 5.2.5. Latin America
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Bone Marrow Transplantation Market Outlook

  • 6.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.1.1. By Country
    • 6.1.2. By Type of Transplant
    • 6.1.3. By Indication
    • 6.1.4. By End User
  • 6.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 6.3.1. Autologous Bone Marrow Transplantation
    • 6.3.2. Allogeneic Bone Marrow Transplantation
    • 6.3.3. Syngeneic Transplantation
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 6.4.1. Leukemia
    • 6.4.2. Lymphoma
    • 6.4.3. Myeloma
    • 6.4.4. Aplastic Anemia
    • 6.4.5. Sickle Cell Anemia
    • 6.4.6. Others
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 6.5.1. Hospitals
    • 6.5.2. Multispecialty Clinics
    • 6.5.3. Ambulatory Surgical Centers
    • 6.5.4. Cancer Research Institutes
  • 6.6. Market Attractiveness Analysis

7. Europe Bone Marrow Transplantation Market Outlook

  • 7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Type of Transplant
    • 7.1.3. By Indication
    • 7.1.4. By End User
  • 7.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 7.3.1. Autologous Bone Marrow Transplantation
    • 7.3.2. Allogeneic Bone Marrow Transplantation
    • 7.3.3. Syngeneic Transplantation
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 7.4.1. Leukemia
    • 7.4.2. Lymphoma
    • 7.4.3. Myeloma
    • 7.4.4. Aplastic Anemia
    • 7.4.5. Sickle Cell Anemia
    • 7.4.6. Others
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.5.1. Hospitals
    • 7.5.2. Multispecialty Clinics
    • 7.5.3. Ambulatory Surgical Centers
    • 7.5.4. Cancer Research Institutes
  • 7.6. Market Attractiveness Analysis

8. East Asia Bone Marrow Transplantation Market Outlook:

  • 8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Type of Transplant
    • 8.1.3. By Indication
    • 8.1.4. By End User
  • 8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 8.3.1. Autologous Bone Marrow Transplantation
    • 8.3.2. Allogeneic Bone Marrow Transplantation
    • 8.3.3. Syngeneic Transplantation
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 8.4.1. Leukemia
    • 8.4.2. Lymphoma
    • 8.4.3. Myeloma
    • 8.4.4. Aplastic Anemia
    • 8.4.5. Sickle Cell Anemia
    • 8.4.6. Others
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.5.1. Hospitals
    • 8.5.2. Multispecialty Clinics
    • 8.5.3. Ambulatory Surgical Centers
    • 8.5.4. Cancer Research Institutes
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Bone Marrow Transplantation Market Outlook:

  • 9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Type of Transplant
    • 9.1.3. By Indication
    • 9.1.4. By End User
  • 9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.2.1. India
    • 9.2.2. Southeast Asia
    • 9.2.3. ANZ
    • 9.2.4. Rest of South Asia & Oceania
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 9.3.1. Autologous Bone Marrow Transplantation
    • 9.3.2. Allogeneic Bone Marrow Transplantation
    • 9.3.3. Syngeneic Transplantation
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 9.4.1. Leukemia
    • 9.4.2. Lymphoma
    • 9.4.3. Myeloma
    • 9.4.4. Aplastic Anemia
    • 9.4.5. Sickle Cell Anemia
    • 9.4.6. Others
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.5.1. Hospitals
    • 9.5.2. Multispecialty Clinics
    • 9.5.3. Ambulatory Surgical Centers
    • 9.5.4. Cancer Research Institutes
  • 9.6. Market Attractiveness Analysis

10. Latin America Bone Marrow Transplantation Market Outlook:

  • 10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Type of Transplant
    • 10.1.3. By Indication
    • 10.1.4. By End User
  • 10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 10.3.1. Autologous Bone Marrow Transplantation
    • 10.3.2. Allogeneic Bone Marrow Transplantation
    • 10.3.3. Syngeneic Transplantation
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 10.4.1. Leukemia
    • 10.4.2. Lymphoma
    • 10.4.3. Myeloma
    • 10.4.4. Aplastic Anemia
    • 10.4.5. Sickle Cell Anemia
    • 10.4.6. Others
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.5.1. Hospitals
    • 10.5.2. Multispecialty Clinics
    • 10.5.3. Ambulatory Surgical Centers
    • 10.5.4. Cancer Research Institutes
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Bone Marrow Transplantation Market Outlook:

  • 11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Type of Transplant
    • 11.1.3. By Indication
    • 11.1.4. By End User
  • 11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Type of Transplant, 2025-2032
    • 11.3.1. Autologous Bone Marrow Transplantation
    • 11.3.2. Allogeneic Bone Marrow Transplantation
    • 11.3.3. Syngeneic Transplantation
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 11.4.1. Leukemia
    • 11.4.2. Lymphoma
    • 11.4.3. Myeloma
    • 11.4.4. Aplastic Anemia
    • 11.4.5. Sickle Cell Anemia
    • 11.4.6. Others
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.5.1. Hospitals
    • 11.5.2. Multispecialty Clinics
    • 11.5.3. Ambulatory Surgical Centers
    • 11.5.4. Cancer Research Institutes
  • 11.6. Market Attractiveness Analysis

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations